| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BI-2536 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.3 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.065 | 0.3 |
| mRNA | QL-XII-61 | GDSC1000 | pan-cancer | AAC | -0.064 | 0.3 |
| mRNA | Erlotinib | FIMM | pan-cancer | AAC | -0.36 | 0.3 |
| mRNA | AMG-706 | GDSC1000 | pan-cancer | AAC | 0.051 | 0.3 |
| mRNA | EKB-569 | GDSC1000 | pan-cancer | AAC | 0.047 | 0.3 |
| mRNA | BRD-K02251932 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.3 |
| mRNA | lapatinib | UHNBreast | pan-cancer | AAC | -0.3 | 0.3 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.077 | 0.3 |
| mRNA | BCL-LZH-4 | CTRPv2 | pan-cancer | AAC | 0.065 | 0.3 |